Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomas.
Righi L, Righi A, Vatrano S, Rapa I, Listì A, Metovic J, Rocca M, Salone M, Giovenali P, Sidoni A, Tabbò F, Dei Tos AP, Volante M, Papotti M. Righi L, et al. Among authors: righi a. Virchows Arch. 2021 Jun;478(6):1125-1134. doi: 10.1007/s00428-020-02990-7. Epub 2021 Jan 9. Virchows Arch. 2021. PMID: 33420836
Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice.
Vavala T, Malapelle U, Veggiani C, Ludovini V, Papotti M, Leone A, Graziano P, Minari R, Bono F, Sapino A, Manotti L, Troncone G, Pisapia P, Girlando S, Buffoni L, Righi L, Colantonio I, Bertetto O, Novello S. Vavala T, et al. Among authors: righi l. J Clin Pathol. 2022 Apr;75(4):234-240. doi: 10.1136/jclinpath-2020-207339. Epub 2021 Jan 28. J Clin Pathol. 2022. PMID: 33509945
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective.
Malapelle U, Pilotto S, Passiglia F, Pepe F, Pisapia P, Righi L, Listì A, Bironzo P, Belluomini L, Tabbò F, Reale ML, Russo G, De Luca C, Novello S, Troncone G. Malapelle U, et al. Among authors: righi l. Crit Rev Oncol Hematol. 2021 Apr;160:103300. doi: 10.1016/j.critrevonc.2021.103300. Epub 2021 Mar 17. Crit Rev Oncol Hematol. 2021. PMID: 33744362 Review.
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations.
Bironzo P, Reale ML, Sperone T, Tabbò F, Caglio A, Listì A, Passiglia F, Di Maio M, Righi L, Bussolino F, Scagliotti GV, Novello S. Bironzo P, et al. Among authors: righi l. Cancers (Basel). 2021 May 17;13(10):2425. doi: 10.3390/cancers13102425. Cancers (Basel). 2021. PMID: 34067823 Free PMC article.
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center.
Luca C, Pepe F, Pisapia P, Iaccarino A, Righi L, Listì A, Russo G, Campione S, Pagni F, Nacchio M, Conticelli F, Russo M, Fabozzi T, Vigliar E, Bellevicine C, Rocco D, Laudati S, Iannaci G, Daniele B, Gridelli C, Cortinovis DL, Novello S, Molina-Vila MA, Rosell R, Troncone G, Malapelle U. Luca C, et al. Among authors: righi l. Per Med. 2022 Sep;19(5):395-401. doi: 10.2217/pme-2022-0020. Epub 2022 Jul 8. Per Med. 2022. PMID: 35801400
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences.
Tabbò F, Muscarella LA, Gobbini E, Trombetta D, Castellana S, Rigutto A, Galetta D, Maiello E, Martelli O, Tiseo M, Scotti V, Ghilardi L, Gregorc V, Sergi C, Pilotto S, Del Conte A, Cappuzzo F, Cortinovis D, Osman G, Bareggi C, Di Maio M, Rossi A, Rossi G, Bria E, Volante M, Scagliotti GV, Graziano P, Novello S, Righi L. Tabbò F, et al. Among authors: righi l. Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28. Eur J Cancer. 2022. PMID: 36044814
207 results